Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414442608> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2414442608 endingPage "813" @default.
- W2414442608 startingPage "797" @default.
- W2414442608 abstract "Artemisinin or Qinghaosu (QHS) and its derivatives (mainly artemether and artesunate) are novel and the most rapidly acting antimalarial drugs, effective in adults and children against all the Plasmodium of humans, including multi-drug resistant Plasmodium falciparum. Resistance to these drugs has not been identified so far. QHS derivatives are very well tolerated and there is no evidence of serious clinical toxicity in man. The neurotoxicity seen in animals after high doses of certain compounds has not been reported in humans. In the treatment of severe malaria, QHS administered by either the intramuscular (artemether and artesunate) or intravenous (artesunate) route, are at least as effective as quinine, and are simpler to use. Intramuscular artemether appears to be an excellent alternative to intravenous quinine, which is specially important since quinine resistance is common in Asia and a decrease of sensitivity to quinine has been reported in Africa. For the treatment of uncomplicated malaria, the use of QHS must be highly selective. Treatment by QHS is only totally justifiable in areas where multi-drug resistant strains are prevalent and always concurrently with an other effective, longer-acting, antimalarial drug (mefloquine, preferably). This combination approach is associated with an accelerated antimalarial response. It avoids or limits the risk of recrudescences, and protects both drugs from the development of resistance. Artemether and artesunate have also been administered by the rectal route with highly promising results for treatment of severe malaria. This route eliminates several disadvantages or risks associated with injections. The best indication for rectal administration will be probably a rescue treatment of severe malaria in rural and poorly equipped dispensaries before transfer to hospital for treatment using conventional modalities. All QHS derivatives should not be used for chemophophylaxis." @default.
- W2414442608 created "2016-06-24" @default.
- W2414442608 creator A5019417747 @default.
- W2414442608 date "1999-01-01" @default.
- W2414442608 modified "2023-09-25" @default.
- W2414442608 title "[Current data on major novel antiamalaria drugs: Artemisinin (qinghaosu) derivatives]." @default.
- W2414442608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10437302" @default.
- W2414442608 hasPublicationYear "1999" @default.
- W2414442608 type Work @default.
- W2414442608 sameAs 2414442608 @default.
- W2414442608 citedByCount "7" @default.
- W2414442608 countsByYear W24144426082012 @default.
- W2414442608 countsByYear W24144426082017 @default.
- W2414442608 crossrefType "journal-article" @default.
- W2414442608 hasAuthorship W2414442608A5019417747 @default.
- W2414442608 hasConcept C114851261 @default.
- W2414442608 hasConcept C203014093 @default.
- W2414442608 hasConcept C2776120307 @default.
- W2414442608 hasConcept C2777199930 @default.
- W2414442608 hasConcept C2777617192 @default.
- W2414442608 hasConcept C2778048844 @default.
- W2414442608 hasConcept C2778059366 @default.
- W2414442608 hasConcept C2778118209 @default.
- W2414442608 hasConcept C2778371730 @default.
- W2414442608 hasConcept C2780035454 @default.
- W2414442608 hasConcept C2908793570 @default.
- W2414442608 hasConcept C71924100 @default.
- W2414442608 hasConcept C86803240 @default.
- W2414442608 hasConcept C89423630 @default.
- W2414442608 hasConcept C98274493 @default.
- W2414442608 hasConceptScore W2414442608C114851261 @default.
- W2414442608 hasConceptScore W2414442608C203014093 @default.
- W2414442608 hasConceptScore W2414442608C2776120307 @default.
- W2414442608 hasConceptScore W2414442608C2777199930 @default.
- W2414442608 hasConceptScore W2414442608C2777617192 @default.
- W2414442608 hasConceptScore W2414442608C2778048844 @default.
- W2414442608 hasConceptScore W2414442608C2778059366 @default.
- W2414442608 hasConceptScore W2414442608C2778118209 @default.
- W2414442608 hasConceptScore W2414442608C2778371730 @default.
- W2414442608 hasConceptScore W2414442608C2780035454 @default.
- W2414442608 hasConceptScore W2414442608C2908793570 @default.
- W2414442608 hasConceptScore W2414442608C71924100 @default.
- W2414442608 hasConceptScore W2414442608C86803240 @default.
- W2414442608 hasConceptScore W2414442608C89423630 @default.
- W2414442608 hasConceptScore W2414442608C98274493 @default.
- W2414442608 hasIssue "4" @default.
- W2414442608 hasLocation W24144426081 @default.
- W2414442608 hasOpenAccess W2414442608 @default.
- W2414442608 hasPrimaryLocation W24144426081 @default.
- W2414442608 hasRelatedWork W1498570182 @default.
- W2414442608 hasRelatedWork W1989789547 @default.
- W2414442608 hasRelatedWork W1991072114 @default.
- W2414442608 hasRelatedWork W1992471109 @default.
- W2414442608 hasRelatedWork W2009589913 @default.
- W2414442608 hasRelatedWork W2025552498 @default.
- W2414442608 hasRelatedWork W2031920093 @default.
- W2414442608 hasRelatedWork W2033923082 @default.
- W2414442608 hasRelatedWork W2038553016 @default.
- W2414442608 hasRelatedWork W2040866238 @default.
- W2414442608 hasRelatedWork W2050378568 @default.
- W2414442608 hasRelatedWork W2056183462 @default.
- W2414442608 hasRelatedWork W2100536384 @default.
- W2414442608 hasRelatedWork W2143095980 @default.
- W2414442608 hasRelatedWork W2145130342 @default.
- W2414442608 hasRelatedWork W2150190443 @default.
- W2414442608 hasRelatedWork W2418452906 @default.
- W2414442608 hasRelatedWork W2431405658 @default.
- W2414442608 hasRelatedWork W3202973394 @default.
- W2414442608 hasRelatedWork W1977347593 @default.
- W2414442608 hasVolume "183" @default.
- W2414442608 isParatext "false" @default.
- W2414442608 isRetracted "false" @default.
- W2414442608 magId "2414442608" @default.
- W2414442608 workType "article" @default.